Although pancreatic cancer (PC) was considered in the past an orphan cancer type due to
its low incidence, it may become in the future one of the leading causes of cancer death …

Small-bowel tumors represent a rare entity comprising 0.6% of all new cancer cases in the
US, and only 3% of all gastrointestinal neoplasms. They are a heterogenous group of …

Neuroendocrine neoplasms (NENs) include a heterogeneous group of tumors derived from
neuroendocrine cells, most commonly arising from the gastro-entero-pancreatic (GEP) and …

Abstract Purpose Pancreatic neuroendocrine neoplasms (PNENs) are a group of clinically
rare and heterogeneous tumors of the pancreas. Currently there are no studies investigating …

Our understanding about the epidemiological aspects, pathogenesis, molecular diagnosis,
and targeted therapies of neuroendocrine neoplasms (NENs) have drastically advanced in …

Gastroenteropancreatic neuroendocrine neoplasms are a heterogenous group of rare
neoplasms that are increasingly being discovered, often incidentally, throughout the …

Pancreatic neuroendocrine neoplasms (pNENs) are rare cancers with broad challenges for
their management. The main clinical obstacles are the high rate of patients diagnosed at …

Introduction Surgery is the only cure for neuroendocrine tumors (NETs), with R0 resection
being critical for successful tumor removal. Early detection of residual disease is key for …

Neuroendocrine tumours commonly metastasise to the liver, particularly those arising from
the intestinal tract and pancreas. Whilst surgery offers the only approach with intent to cure …

Pancreatic neuroendocrine neoplasms (PanNENs) are the neuroendocrine neoplasms with
greatest rate of increase in incidence. Approximately 10% of PanNENs arise as inherited …